Navigation Links
Free Diabetes Health Program Saturday, Oct. 30 at Jefferson State Community College
Date:10/27/2010

BIRMINGHAM, Ala., Oct. 27 /PRNewswire/ -- The Institute for Health Protection (IHP), in partnership with Roche Diabetes Care, the makers of ACCU-CHEK® products and services, and Jefferson State Community College, will host a free community diabetes program at JSCC's Shelby-Hoover campus this Saturday, Oct. 30 from 9 a.m. to 2 p.m. To register for the event, please call (917) 210-2466 or e-mail JianiY@IHPonline.net.

The program will focus on education, prevention and management of Type 2 diabetes. Highlights of the day's event include free diabetes and health screenings, healthcare specialist consultations and a complimentary lunch for all program participants. A panel of prominent local healthcare providers and community leaders, including Alabama State Rep. Mary Sue McClurkin, will be presenting valuable and relevant educational information as well as leading an interactive Q&A session for participants.What:Free Diabetes Health and Screening ProgramWho:Institute for Health ProtectionRoche Diabetes CareJefferson State Community CollegeAlabama State Rep. Mary Sue McClurkinVarious health and community leadersWhen:Saturday, Oct. 30, 2010Time:9 a.m.-2 p.m. (doors open at 8:30 a.m.)Where:Jefferson State Community CollegeShelby-Hoover Campus4600 Valleydale RoadBirmingham, Ala. 35242This event in Birmingham is part of a series of programs focusing on diabetes awareness and prevention that IHP and Roche Diabetes Care have been conducting nation-wide. The overall goal for these programs is to provide educational information for those at-risk for developing diabetes as well as those who have been diagnosed with diabetes.

IHP is a national organization specializing in translating evidence-based healthcare knowledge into everyday practice and patient-centric care. Through partnerships with key stakeholders, from state government officials to local universities, IHP has been able to develop and execute effective and meaningful educational programs for improving the health status of diverse communities. For more information about IHP, please visit www.ihponline.net

Contact: Jiani Yujianiy@ihponline.net(917) 210-2466
'/>"/>

SOURCE Institute for Health Protection
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
3. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
4. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
5. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
8. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
9. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
10. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
11. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... ... On Tuesday, April 26, 2016 members of the HomeTown Health network, a ... Deal on SB 258, the “Rural Health Care Relief” Bill. , The bill, which ... to individuals and corporations which donate directly to a “rural hospital” in Georgia, and ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... ... 2016 , ... Mobility Designed is redefining mobility with their patent pending ... Crutch evenly distributes body weight from the elbow to the forearm. In consumer ... than with other crutches. , Co-founders Max and Liliana Younger were inspired to design ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type of skin ... blame for the majority of skin cancer deaths. More than 10,000 people are expected to ... at diagnosis is 62, it is the one of the most commonly diagnosed cancers in ...
Breaking Medicine News(10 mins):